Melanotan-2
MT-II, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2
Synthetic analogue of α-MSH that stimulates melanogenesis for skin tanning and may increase sexual arousal.
Completed
PHASE2
NCT00100789
S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00534859
PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI
Abiomed Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT02348268
Myofascial Release Therapy and Mechanical Neck Pain
FREMAP Mutual Insurance Company for Occupational Accidents and Diseases
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06069323
Therapeutic Use of rTMS in Pediatric ASD and ADHD Cohorts
Ospedali Riuniti di Foggia
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT02943785
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
Daiichi Sankyo
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT02448810
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer
Baxalta now part of Shire
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT01198158
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT05803421
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Eli Lilly and Company
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01802333
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03971474
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00006366
Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
Radiation Therapy Oncology Group
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00002665
SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
NA
NCT03093961
REDUCE LAP-HFREF TRIAL
Corvia Medical
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT03180294
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
NRG Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00039494
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT01156753
A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer
Celldex Therapeutics
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT03001817
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function
Kowa Research Institute, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT05546476
Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15
Pfizer
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE1, PHASE2
NCT00924352
Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Accelerated Community Oncology Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01414608
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
GOG Foundation
INTERVENTIONAL
Updated Dec 15, 2025